FDA Adds Warning of Intestinal Blockages to Ozempic Label

The FDA has received more than 8,500 reports of gastrointestinal issues among people taking medications like Ozempic and Wegovy, the latter of which is approved for weight loss.

source https://www.webmd.com/obesity/news/20230928/risk-of-intestinal-blockage-added-to-ozempic-label?src=RSS_PUBLIC